Myriad Genetics Competitors and Similar CompaniesClear all
Myriad Genetics's competitors and similar companies include Asuragen, Biora Therapeutics, Foundation Medicine, Genomic Health, Ambry Genetics and Natera.
 Biora Therapeutics Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services. |  Foundation Medicine Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies. |  Genomic Health Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests. |  Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. | ||||
Founding Date | Founding Date 1991 | Founding Date 2006 | Founding Date 2010 | Founding Date 2010 | Founding Date 2000 | Founding Date 1999 | Founding Date 2004 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||||
Locations | Locations Salt Lake City, US HQ Paris, FR Munich, DE Tokyo, JP Amsterdam, NL Zürich, CH | Locations Austin, US HQ | Locations San Diego, US HQ San Diego, US | Locations Boston, US HQ Penzberg, DE Morrisville, US San Diego, US | Locations Redwood City, US HQ Köln, DE Chiyoda City, JP London, GB | Locations Aliso Viejo, US HQ Aliso Viejo, US | Locations Austin, US HQ San Carlos, US |
Employees | Employees 2,700 | Employees 1282% increase | Employees 5456% decrease | Employees 1,8031% decrease | Employees 311 | Employees 9094% increase | Employees 3,28211% increase |
Valuation ($) | Valuation ($) 2 b | Valuation ($) N/A | Valuation ($) 16.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 15.4 b |
Financial | |||||||
Revenue (est.) | Revenue (est.) $824.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $4k (FY, 2023) | Revenue (est.) $152.9m (FY, 2017) | Revenue (est.) $394.1m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods $247.9m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $85.3m (FY, 2017) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $576.6m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $67.6m (FY, 2017) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($365.9m) (FY, 2025) | Net income N/A | Net income ($124.1m) (FY, 2023) | Net income ($161.5m) (FY, 2017) | Net income $25.7m (FY, 2018) | Net income N/A | Net income ($208.2m) (FY, 2025) |
Operating ⚠ | |||||||
Facilities Leased, sq. ft. | Facilities Leased, sq. ft. 500.1 k (FY, 2022) | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. N/A | Facilities Leased, sq. ft. 272 k (FY, 2021) |
Patent Applications (US) | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) N/A | Patent Applications (US) 50 (Jul, 2022) | Patent Applications (US) N/A | Patent Applications (US) 1 (Aug, 2022) | Patent Applications (US) N/A |
Products | Products 10 (FY, 2021) | Products N/A | Products N/A | Products 3 (Jul, 2022) | Products N/A | Products N/A | Products N/A |
Trademark Applications (US) | Trademark Applications (US) N/A | Trademark Applications (US) N/A | Trademark Applications (US) N/A | Trademark Applications (US) 9 (Jul, 2022) | Trademark Applications (US) N/A | Trademark Applications (US) 6 (Aug, 2022) | Trademark Applications (US) N/A |
Trademarks (US) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) 25 (Jul, 2022) | Trademarks (US) N/A | Trademarks (US) 65 (Aug, 2022) | Trademarks (US) N/A |
Funding | |||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 80m | Total funding raised $ 138.5m | Total funding raised $ 96.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 154.1m |
For sources of this data, please see the company profile
View Company Profiles
Biora Therapeutics
HQ
San Diego, US
Employees
54
Biora Therapeutics (formerly known as Ascendant Mdx and Progenity) is a biotech company that provides reimagining therapeutic services.
View companyFoundation Medicine
HQ
Boston, US
Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies.
View companyGenomic Health
HQ
Redwood City, US
Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests.
View company